THE WHY HOW DO COMPANY, Inc. Logo

THE WHY HOW DO COMPANY, Inc.

A corporate regeneration platform for business turnarounds, M&A, and succession solutions.

3823 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
新宿区愛住町22
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

THE WHY HOW DO COMPANY, Inc. operates a multifaceted 'corporate regeneration platform' focused on fostering mutual growth for companies and their personnel. The company's strategic business model centers on three core areas: conventional business turnarounds, innovative 'non-sale business succession' solutions, and functioning as a 'business model general trading company.' Through these services, it aims to establish a unique position as a comprehensive developer within the M&A industry, prioritizing value creation and sustainable growth. Historically known as Acrodea Inc., its operations also encompass software development, IoT solutions, and entertainment-related businesses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-16 09:08
Board/Management Information
臨時報告書
Japanese 21.7 KB
2025-07-14 09:46
Legal Proceedings Report
臨時報告書
Japanese 18.9 KB
2025-05-27 09:37
Board/Management Information
臨時報告書
Japanese 19.4 KB
2025-04-14 08:49
Regulatory News Service
臨時報告書
Japanese 19.6 KB
2025-04-14 08:47
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-04-14 08:45
Interim Report
半期報告書-第21期(2024/09/01-2025/08/31)
Japanese 294.3 KB
2025-01-29 07:42
Regulatory News Service
臨時報告書
Japanese 18.3 KB
2025-01-14 08:09
Regulatory News Service
臨時報告書
Japanese 19.4 KB
2024-11-29 08:43
Post-Annual General Meeting Information
臨時報告書
Japanese 20.1 KB
2024-11-29 08:41
Registration Form
確認書
Japanese 8.1 KB
2024-11-29 08:40
Governance Information
内部統制報告書-第20期(2023/09/01-2024/08/31)
Japanese 25.1 KB
2024-11-29 08:37
Annual Report
有価証券報告書-第20期(2023/09/01-2024/08/31)
Japanese 1.3 MB
2024-11-13 07:32
Annual Report
訂正有価証券報告書-第15期(2018/09/01-2019/08/31)
Japanese 1.4 MB
2024-10-18 10:13
Regulatory News Service
臨時報告書
Japanese 20.9 KB
2024-08-15 08:22
Regulatory News Service
訂正有価証券報告書-第15期(2018/09/01-2019/08/31)
Japanese 675.6 KB

Automate Your Workflow. Get a real-time feed of all THE WHY HOW DO COMPANY, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for THE WHY HOW DO COMPANY, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
DT&CRO CO., Ltd. Logo
A full-service CRO for pharma & biotech, from non-clinical studies to FDA approval support.
South Korea 383930
DUSKIN CO.,LTD. Logo
Franchises cleaning rentals and services for homes and businesses, and operates food chains.
Japan 4665
D.Western Therapeutics Institute, Inc. Logo
Biotech firm discovering and licensing drug candidates, focusing on kinase inhibitors.
Japan 4576
ECHOMARKETING Co.,Ltd. Logo
Global agency accelerating sales with data-driven, full-funnel digital marketing.
South Korea 230360
Eezy Oyj Logo
HR services firm for the full employment lifecycle, from recruitment to freelancer support.
Finland EEZY
Enjin Co., Ltd. Logo
PR firm for SMEs and medical institutions, offering consulting and a media matching platform.
Japan 7370
Ensol Biosciences Inc. Logo
Develops AI-discovered peptide drugs for cancer, osteoarthritis, and Alzheimer's disease.
South Korea 140610
Eutilex Co.,Ltd. Logo
Develops T-cell and antibody immunotherapies for cancer and autoimmune diseases.
South Korea 263050
Evogene Ltd. Logo
AI-powered platform designing life-science solutions for health, ag, and industrial sectors.
Israel EVGN
EXACT Therapeutics AS Logo
Biopharma firm using ultrasound to enhance drug delivery for oncology via its ACT® platform.
Norway EXTX

Talk to a Data Expert

Have a question? We'll get back to you promptly.